WallStSmart
NUWE

Nuwellis Inc

NASDAQ: NUWE · HEALTHCARE · MEDICAL DEVICES

$1.03
-61.21% today

Updated 2026-06-05

Market cap
$491910.00
P/E ratio
P/S ratio
0.06x
EPS (TTM)
$-26.89
Dividend yield
52W range
$0 – $17
Volume
1.1M

Nuwellis Inc (NUWE) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$2.73M$422040.00$108302.00$400025.00$400025.00$59000.00$295000.00$59000.00$1.29M$3.55M$5.00M$5.51M$7.44M$7.92M$8.54M$8.86M$8.74M$8.27M
Revenue growth (YoY)-84.6%-74.3%+269.4%+0.0%-100.0%+400.0%-80.0%+2084.7%+175.6%+40.7%+10.3%+35.0%+6.5%+7.9%+3.8%-1.4%-5.4%
Cost of revenue$325000.00$713000.00$2.76M$3.67M$2.66M$3.38M$3.43M$3.79M$3.88M$2.91M$3.15M
Gross profit$2.73M$422040.00$108302.00$400025.00$400025.00$59000.00$295000.00$-266000.00$576000.00$790000.00$1.33M$2.85M$4.06M$4.49M$4.75M$4.98M$5.83M$5.12M
Gross margin100.0%100.0%100.0%100.0%100.0%100.0%100.0%-450.8%44.7%22.2%26.6%51.7%54.5%56.7%55.7%56.2%66.7%62.0%
R&D$8.73M$5.58M$2.52M$2.95M$2.95M$11.20M$8.00M$13.50M$16.87M$17.67M$8.11M$1.48M$3.05M$4.67M$3.67M$4.98M$4.34M$5.42M$3.21M$2.71M
SG&A$3.13M$3.25M$3.49M$3.07M$3.07M$10.17M$15.31M$16.29M$17.42M$19.04M$17.58M$18.25M$13.46M$13.52M
Operating income$-9.79M$-9.32M$-6.75M$-6.22M$-6.22M$-16.56M$-14.87M$-22.87M$-25.79M$-25.96M$-15.66M$-14.81M$-17.04M$-18.11M$-17.03M$-19.53M$-17.17M$-17.63M$-10.99M$-11.11M
Operating margin-358.3%-2207.6%-6236.5%-1554.8%-1554.8%-38764.4%-8741.4%-43996.6%-1215.1%-416.9%-340.9%-328.5%-228.8%-246.5%-201.0%-198.9%-125.7%-134.3%
EBITDA$-8.64M$-6.46M$-6.39M$-11.81M$-11.81M$-16.26M$-14.70M$-22.69M$-25.51M$-25.64M$-14.64M$-10.09M$-16.80M$-17.87M$-16.65M$-19.06M$-4.90M$-16.36M$-10.53M$-10.69M
EBITDA margin-316.3%-1531.6%-5898.8%-2952.1%-2952.1%-38450.8%-8647.5%-43455.9%-1136.2%-284.0%-336.2%-324.2%-223.8%-240.6%-57.3%-184.5%-120.5%-129.3%
EBIT$-8.70M$-6.54M$-6.44M$-11.86M$-11.86M$-16.31M$-14.84M$-22.87M$-25.79M$-25.96M$-15.34M$-10.86M$-17.04M$-18.11M$-17.03M$-19.55M$-5.27M$-16.72M$-10.84M$-11.11M
Interest expense$0.00$0.00$0.00$0.00$0.00$251000.00$33000.00$100000.00$49000.00$743000.00$504000.00$2.54M$10000.00$0.00$2.40M$43000.00$9.25M$3.48M$5.61M$10.55M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-9.79M$-9.32M$-6.52M$-5.55M$-5.55M$-16.20M$-14.06M$-21.76M$-25.59M$-26.58M$-15.79M$-13.38M$-17.03M$-18.11M$-15.84M$-19.55M$-14.53M$-20.21M$-11.16M$-17.52M
Net income growth (YoY)+4.8%+30.0%+14.8%+0.0%-191.7%+13.2%-54.7%-17.6%-3.9%+40.6%+15.3%-27.3%-6.4%+12.6%-23.5%+25.7%-39.1%+44.8%-56.9%
Profit margin-358.3%-2207.6%-6020.4%-1387.9%-1387.9%-36878.0%-8673.6%-45055.9%-1225.1%-376.6%-340.8%-328.7%-212.8%-246.9%-170.0%-228.0%-127.7%-211.9%

Frequently asked questions

What is Nuwellis Inc's revenue?

Nuwellis Inc's trailing twelve-month revenue is $8.77M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is NUWE?

In its most recent fiscal year, NUWE ran a gross margin of 61.96%, an operating margin of -134.29%, and a net margin of -211.86%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does NUWE generate?

NUWE produced $-10.90M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is NUWE's balance sheet healthy?

NUWE holds $1.08M in cash and equivalents against — in long-term debt, on $2.62M of shareholder equity. That debt is best read against the cash flow the business throws off each year.